Those finances are *not* a good read. They have spent significant $ on the sales they have - hopefully still growing but concerning to see 1/4 YoY revenue decreased.
Very much similar to Nextstellis and (unfortunately) supports the sentiment in the market - High Risk.
They'll need to slice significant costs out to turn a Profit (net, not gross)
- Forums
- ASX - By Stock
- MYX
- Ann: MYX signs license agreement for women's health products
Ann: MYX signs license agreement for women's health products, page-98
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
|
|||||
Last
$4.40 |
Change
0.000(0.00%) |
Mkt cap ! $374.3M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 164 | $4.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.42 | 164 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 164 | 4.370 |
1 | 164 | 4.360 |
1 | 164 | 4.350 |
1 | 164 | 4.340 |
1 | 164 | 4.330 |
Price($) | Vol. | No. |
---|---|---|
4.420 | 164 | 1 |
4.430 | 164 | 1 |
4.440 | 2664 | 3 |
4.450 | 164 | 1 |
4.460 | 164 | 1 |
Last trade - 09.29am 16/07/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online